Galecto Inc (GLTO) is a Healthcare · Biotechnology company listed on NASDAQ. Price $22.78 (-7.13%), Market cap $1.73B, 52-week low–high $2.58 ~ $34.14.
Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.
Financial statements, price targets, institutional (13F) holdings and related news for Galecto Inc are updated in real time on BlackAll Trade.
Galecto Inc trades at $22.78 (-7.13%). Real-time quotes and charts are available on BlackAll Trade.
Galecto Inc has a market cap of about $1.73B.
Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a